Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism

被引:311
作者
Wan, Xingyong [1 ]
Xu, Chengfu [1 ]
Lin, Yiming [1 ]
Lu, Chao [1 ]
Li, Dejian [1 ]
Sang, Jianzhong [1 ]
He, Haijian [1 ]
Liu, Xiao [1 ]
Li, Youming [1 ]
Yu, Chaohui [1 ]
机构
[1] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Fatty liver; Insulin resistance; Uric acid; Hyperuricemia; NLRP3; inflammasome; NONALCOHOLIC FATTY LIVER; METABOLIC SYNDROME; BLOOD-PRESSURE; DISEASE; ACTIVATION; STEATOHEPATITIS; ASSOCIATION; HYPERURICEMIA; PROGRESSION; INHIBITION;
D O I
10.1016/j.jhep.2015.11.022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Hyperuricemia significantly increases risk of non-alcoholic fatty liver disease (NAFLD) and insulin resistance. However, the mechanisms responsible for this association are as yet unclear. This study aimed to investigate the effects and underlying mechanisms of uric acid on development of NAFLD and insulin resistance. Methods: We initially analyzed the impact of uric acid on the development of hepatic steatosis and insulin resistance in mice and in two cell models, HepG2 and L02. Subsequently, we studied the role of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome in uric acid-induced fat accumulation and insulin signaling impairment. Results: We found that uric acid directly induces hepatocyte fat accumulation, insulin resistance, and insulin signaling impairment both in vivo and in vitro. We also found that uric acid induced NLRP3 inflammasome activation, whereas lowering uric acid by allopurinol inhibited NLRP3 inflammasome activation in a high fat diet mouse model of NAFLD. Moreover, knocking down NLRP3 expression significantly attenuated uric acid-induced fat accumulation both in HepG2 cells and L02 cells. Knocking down NLRP3 expression also rescued uric acid-induced insulin signaling impairment in both cell types. Conclusions: Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome. Uric acid may be a new therapeutic target for NAFLD and insulin resistance. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:925 / 932
页数:8
相关论文
共 41 条
[1]  
Abreu Estela, 2011, Acta Med Port, V24 Suppl 2, P565
[2]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[3]   Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis [J].
Anstee, Quentin M. ;
Targher, Giovanni ;
Day, Christopher P. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (06) :330-344
[4]   Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms [J].
Bugianesi, E ;
Gastaldelli, A ;
Vanni, E ;
Gambino, R ;
Cassader, M ;
Baldi, S ;
Ponti, V ;
Pagano, G ;
Ferrannini, E ;
Rizzetto, M .
DIABETOLOGIA, 2005, 48 (04) :634-642
[5]   Insulin resistance: A metabolic pathway to chronic liver disease [J].
Bugianesi, E ;
McCullough, AJ ;
Marchesini, G .
HEPATOLOGY, 2005, 42 (05) :987-1000
[6]   Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes [J].
Choi, Yea-Jin ;
Shin, Hyun-Soo ;
Choi, Hack Sun ;
Park, Joo-Won ;
Jo, Inho ;
Oh, Eok-Soo ;
Lee, Kang-Yo ;
Lee, Byung-Hoon ;
Johnson, Richard J. ;
Kang, Duk-Hee .
LABORATORY INVESTIGATION, 2014, 94 (10) :1114-1125
[7]   Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids [J].
Cicerchi, Christina ;
Li, Nanxing ;
Kratzer, James ;
Garcia, Gabriela ;
Roncal-Jimenez, Carlos A. ;
Tanabe, Katsuyuki ;
Hunter, Brandi ;
Rivard, Christopher J. ;
Sautin, Yuri Y. ;
Gaucher, Eric A. ;
Johnson, Richard J. ;
Lanaspa, Miguel A. .
FASEB JOURNAL, 2014, 28 (08) :3339-3350
[8]  
Civantos Modino Soralla, 2012, Endocrinol Nutr, V59, P533, DOI 10.1016/j.endonu.2012.06.010
[9]   Human Fatty Liver Disease: Old Questions and New Insights [J].
Cohen, Jonathan C. ;
Horton, Jay D. ;
Hobbs, Helen H. .
SCIENCE, 2011, 332 (6037) :1519-1523
[10]   Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease [J].
Day, C. P. .
LIVER INTERNATIONAL, 2006, 26 (09) :1021-1028